Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy Management (CHEMODEX)
Sponsor: Dr Dominique JOLY / Dr Christine VILLATTE
Terminated
Recruitment difficulties
Other Chemotherapy-induced Peripheral Neuropathy trials with similar outcome
- NCT04770402 · Phase NA · Apr 2023
- NCT03870451 · Phase NA · Feb 2023
- NCT04468230 · Phase PHASE2 · May 2022
Browse all Chemotherapy-induced Peripheral Neuropathy trials
Listed as NCT02271893, this PHASE2 trial focuses on Chemotherapy-induced Peripheral Neuropathy and remains terminated or withdrawn. Sponsored by Dr Dominique JOLY / Dr Christine VILLATTE, it has been updated 9 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Nov 2022 — Jul 2024 [monthly]
Terminated PHASE2
Status: Unknown Status → Terminated
-
Oct 2021 — Nov 2022 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE2
▶ Show 4 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Recruiting PHASE2
Status: Unknown Status → Recruiting
-
Aug 2018 — Mar 2019 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Nov 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dr Dominique JOLY / Dr Christine VILLATTE
- Dr Gisèle PICKERING
- Dr Noémie DELAGE / Dr Fabienne MARCAILLOU / Dr Pascale PICARD
- Pr Claude DUBRAY
- University Hospital, Clermont-Ferrand
For direct contact, visit the study record on ClinicalTrials.gov .